JP2009531322A5 - - Google Patents

Download PDF

Info

Publication number
JP2009531322A5
JP2009531322A5 JP2009500923A JP2009500923A JP2009531322A5 JP 2009531322 A5 JP2009531322 A5 JP 2009531322A5 JP 2009500923 A JP2009500923 A JP 2009500923A JP 2009500923 A JP2009500923 A JP 2009500923A JP 2009531322 A5 JP2009531322 A5 JP 2009531322A5
Authority
JP
Japan
Prior art keywords
optionally substituted
pharmaceutical composition
composition according
hydrogen
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009500923A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009531322A (ja
Filing date
Publication date
Priority claimed from GB0605881A external-priority patent/GB0605881D0/en
Priority claimed from GB0623070A external-priority patent/GB0623070D0/en
Application filed filed Critical
Priority claimed from PCT/GB2007/001012 external-priority patent/WO2007107758A1/en
Publication of JP2009531322A publication Critical patent/JP2009531322A/ja
Publication of JP2009531322A5 publication Critical patent/JP2009531322A5/ja
Pending legal-status Critical Current

Links

JP2009500923A 2006-03-23 2007-03-22 抗菌剤 Pending JP2009531322A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0605881A GB0605881D0 (en) 2006-03-23 2006-03-23 Antibacterial Agents
GB0623070A GB0623070D0 (en) 2006-11-16 2006-11-16 Antibacterial agents
PCT/GB2007/001012 WO2007107758A1 (en) 2006-03-23 2007-03-22 Antibacterial agents

Publications (2)

Publication Number Publication Date
JP2009531322A JP2009531322A (ja) 2009-09-03
JP2009531322A5 true JP2009531322A5 (cg-RX-API-DMAC7.html) 2010-05-06

Family

ID=38045577

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009500923A Pending JP2009531322A (ja) 2006-03-23 2007-03-22 抗菌剤

Country Status (17)

Country Link
US (4) US8088791B2 (cg-RX-API-DMAC7.html)
EP (1) EP1996180B1 (cg-RX-API-DMAC7.html)
JP (1) JP2009531322A (cg-RX-API-DMAC7.html)
KR (1) KR20090017483A (cg-RX-API-DMAC7.html)
CN (1) CN102008459B (cg-RX-API-DMAC7.html)
AT (1) ATE518564T1 (cg-RX-API-DMAC7.html)
AU (1) AU2007228539B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0709110A2 (cg-RX-API-DMAC7.html)
CA (1) CA2648785A1 (cg-RX-API-DMAC7.html)
DK (1) DK1996180T3 (cg-RX-API-DMAC7.html)
EA (1) EA015198B1 (cg-RX-API-DMAC7.html)
IL (1) IL193834A0 (cg-RX-API-DMAC7.html)
MX (1) MX2008011857A (cg-RX-API-DMAC7.html)
MY (1) MY148430A (cg-RX-API-DMAC7.html)
NZ (1) NZ571271A (cg-RX-API-DMAC7.html)
PL (1) PL1996180T3 (cg-RX-API-DMAC7.html)
WO (1) WO2007107758A1 (cg-RX-API-DMAC7.html)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007147336A1 (fr) * 2006-06-13 2007-12-27 Shanghai Institue Of Materia Medica, Chinese Academy Of Sciences Composés non nucléosidiques hétérocycliques, leur préparation, compositions pharmaceutiques, et leur utilisation en tant qu'agents antiviraux
JP2010511682A (ja) 2006-12-04 2010-04-15 アストラゼネカ アクチボラグ 抗菌性の多環系尿素化合物
GB0718335D0 (en) * 2007-09-20 2007-10-31 Prolysis Ltd Antibacterial agents
GB0718735D0 (en) 2007-09-25 2007-11-07 Prolysis Ltd Antibacterial agents
SMT202000257T1 (it) 2008-10-10 2020-07-08 Vm Discovery Inc Composizioni e metodi per il trattamento dei disturbi da uso di alcol, dolore e altre malattie
WO2012007500A2 (de) 2010-07-15 2012-01-19 Bayer Cropscience Ag Neue heterocyclische verbindungen als schädlingsbekämpfungsmittel
WO2012109527A2 (en) 2011-02-10 2012-08-16 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Class of hdac inhibitors expands the renal progenitor cells population and improves the rate of recovery from acute kidney injury
EP2699557B1 (en) 2011-04-20 2017-08-16 Biota Scientific Management Pty Ltd 3-(oxazol-2-yl-ethoxy)- and 3-(thiazol-2-yl-ethoxy)-benzamide derivatives as anti-bacterial agents
US9822108B2 (en) 2012-01-13 2017-11-21 Rutgers, The State University Of New Jersey Antimicrobial agents
EP2822931B1 (en) 2012-03-09 2017-05-03 Inception 2, Inc. Triazolone compounds and uses thereof
CA2868002C (en) 2012-03-21 2021-07-13 Rutgers, The State University Of New Jersey Antimicrobial agents
CN103724360B (zh) * 2012-10-10 2016-08-10 上海医药工业研究院 吡啶(或苯)并噻唑化合物及其中间体、制备方法和应用
US9670236B2 (en) 2012-10-31 2017-06-06 University of Pittsburgh—of the Commonwealth System of Higher Education Class of HDAC inhibitors expands the renal progenitor cells population and improves the rate of recovery from acute kidney injury
CA2891092C (en) * 2012-11-08 2020-12-15 Taxis Pharmaceuticals, Inc. Antimicrobial agents
EP2945936A1 (en) 2012-11-12 2015-11-25 Lupin Limited Thiazole derivatives as alpha 7 nachr modulators
US9676754B2 (en) 2012-12-20 2017-06-13 Inception 2, Inc. Triazolone compounds and uses thereof
EA201690230A1 (ru) 2013-09-06 2016-07-29 Инсепшн 2, Инк. Соединения триазолона и их применения
US9458150B2 (en) 2013-11-08 2016-10-04 Rutgers, The State University Of New Jersey Antimicrobial agents
JP6327841B2 (ja) * 2013-12-06 2018-05-23 住友精化株式会社 芳香族チアゾール化合物の製造方法
WO2015179697A1 (en) 2014-05-21 2015-11-26 Taxis Pharmaceuticals, Inc. Compounds for the treatment of bacterial infections
CN105461585A (zh) * 2014-09-09 2016-04-06 香港理工大学 作为β-内酰胺辅助抗生素的3-氨基苯甲酰胺衍生物、制备方法及应用
WO2017018803A1 (en) 2015-07-27 2017-02-02 Chong Kun Dang Pharmaceutical Corp. 1,3,4-oxadiazole sulfonamide derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same
RU2700696C2 (ru) 2015-07-27 2019-09-19 Чонг Кун Данг Фармасьютикал Корп. 1,3,4,-оксадизоламидное производное соединение в качестве ингибитора гистондеацетилазы 6 и содержащая его фармацевтическая композиция
NZ736432A (en) 2015-07-27 2019-01-25 Chong Kun Dang Pharmaceutical Corp 1,3,4-oxadiazole sulfamide derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same
HUE057544T2 (hu) 2015-08-04 2022-05-28 Chong Kun Dang Pharmaceutical Corp 1,3,4-oxadiazol-származék vegyületek mint hiszton deacetiláz 6 inhibitorok, és ezeket tartalmazó gyógyszerkészítmények
RU2695133C1 (ru) 2015-10-12 2019-07-22 Чонг Кун Данг Фармасьютикал Корп. Производные оксадиазоламина в качестве ингибитора гистондеацетилазы 6 и содержащая их фармацевтическая композиция
US10513528B2 (en) 2016-02-25 2019-12-24 Taxis Pharmaceuticals, Inc. Synthetic processes and intermediates
WO2018183917A1 (en) 2017-03-30 2018-10-04 Taxis Pharmaceuticals, Inc. Synthetic processes and synthetic intermediates
AU2019255310B2 (en) 2018-04-18 2022-11-24 Constellation Pharmaceuticals, Inc. Modulators of methyl modifying enzymes, compositions and uses thereof
CN120097995A (zh) 2018-05-21 2025-06-06 星座制药公司 甲基修饰酶的调节剂、其组合物和用途
CN108929273A (zh) * 2018-06-27 2018-12-04 合肥医工医药有限公司 一种咪唑乙基香草酸醚钠盐的制备方法
KR102316234B1 (ko) 2018-07-26 2021-10-22 주식회사 종근당 히스톤 탈아세틸화효소 6 억제제로서의 1,3,4-옥사다이아졸 유도체 화합물 및 이를 포함하는 약제학적 조성물
EP3643705A1 (en) * 2018-10-24 2020-04-29 Basf Se Pesticidal compounds
AR118673A1 (es) * 2019-04-18 2021-10-20 Syngenta Crop Protection Ag Procedimiento para la preparación de derivados de oxadiazol microbiocidas
EP3976602A4 (en) 2019-05-31 2023-05-31 Chong Kun Dang Pharmaceutical Corp. 1,3,4-OXADIAZOLE HOMOPHTHALIMIDE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE-6 INHIBITOR AND PHARMACEUTICAL COMPOSITION THEREOF
CN111728837A (zh) * 2020-07-22 2020-10-02 万贤能 一种能揉动腹胸和甩蝴蝶袖运动按摩带及其制备方法
CN117510431A (zh) * 2023-11-08 2024-02-06 浙江雅辰药物科技股份有限公司 一种异噻唑-3-酮及其衍生物、合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032617A (en) * 1985-05-03 1991-07-16 Sri International Substituted benzamide radiosensitizers
US5510375A (en) * 1993-11-19 1996-04-23 Warner-Lambert Company Coumarin derivatives as protease inhibitors and antiviral agents
WO2000066120A1 (en) * 1999-05-05 2000-11-09 Merck & Co., Inc. Novel catechols as antimicrobial agents
EP1500643A4 (en) * 2002-04-03 2007-03-28 Dainippon Sumitomo Pharma Co BENZAMIDE DERIVATIVES
WO2004078748A2 (en) * 2003-02-28 2004-09-16 Bayer Pharmaceuticals Corporation Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders
PE20050444A1 (es) * 2003-10-31 2005-08-09 Takeda Pharmaceutical Compuestos de piridina como inhibidores de la peptidasa
JP2006063064A (ja) * 2004-07-27 2006-03-09 Takeda Chem Ind Ltd 受容体作動剤

Similar Documents

Publication Publication Date Title
JP2009531322A5 (cg-RX-API-DMAC7.html)
JP2013544276A5 (cg-RX-API-DMAC7.html)
JP2018115201A5 (cg-RX-API-DMAC7.html)
JP2009519243A5 (cg-RX-API-DMAC7.html)
JP2010506825A5 (cg-RX-API-DMAC7.html)
JP2015520769A5 (cg-RX-API-DMAC7.html)
JP2006077019A5 (cg-RX-API-DMAC7.html)
JP2019500387A5 (cg-RX-API-DMAC7.html)
RU2009118602A (ru) Производное индола
JP2005523922A5 (cg-RX-API-DMAC7.html)
HRP20100677T1 (hr) IMIDAZO[1,2-a]PIRIDINSKI SPOJEVI KAO INHIBITORI VEGF-R2
JP2013510884A5 (cg-RX-API-DMAC7.html)
JP2007505877A5 (cg-RX-API-DMAC7.html)
JP2012502974A5 (cg-RX-API-DMAC7.html)
JP2014502988A5 (cg-RX-API-DMAC7.html)
JP2015511613A5 (cg-RX-API-DMAC7.html)
JP2017526677A5 (cg-RX-API-DMAC7.html)
JP2013545820A5 (cg-RX-API-DMAC7.html)
PE20061305A1 (es) Compuestos derivados de fenilacetamidas como inhibidores de proteincinasas
JP2020507589A5 (cg-RX-API-DMAC7.html)
JP2012513416A5 (cg-RX-API-DMAC7.html)
JP2010527984A5 (cg-RX-API-DMAC7.html)
JP2008534453A5 (cg-RX-API-DMAC7.html)
JP2017214387A5 (cg-RX-API-DMAC7.html)
JP2016503778A5 (cg-RX-API-DMAC7.html)